{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:39:22Z","timestamp":1760297962570},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11940-007-0012-7","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T07:44:22Z","timestamp":1214207062000},"page":"256-267","source":"Crossref","is-referenced-by-count":23,"title":["Use of the newer antiepileptic drugs in pediatric epilepsies"],"prefix":"10.1007","volume":"9","author":[{"given":"Amy D.","family":"Malphrus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus A.","family":"Wilfong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,24]]},"reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1212\/01.WNL.0000033622.27961.B6","volume":"60","author":"D. Hirtz","year":"2003","unstructured":"Hirtz D, Berg A, Bettis D, et al.: Practice parameter: treatment of the child with a first unprovoked seizure: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2003, 60:166\u2013175.","journal-title":"Neurology"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"J.A. French","year":"2004","unstructured":"French JA, Kanner AM, Bautista J, et al.: Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1252\u20131260.","journal-title":"Neurology"},{"key":"12_CR3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","volume":"62","author":"J.A. French","year":"2004","unstructured":"French JA, Kanner AM, Bautista J, et al.: Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004, 62:1261\u20131273.","journal-title":"Neurology"},{"key":"12_CR4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1528-1167.2006.00585.x","volume":"47","author":"T. Glauser","year":"2006","unstructured":"Glauser T, Ben-Menachem E, Bourgeois B, et al.: ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006, 47:1091\u20131093.","journal-title":"Epilepsia"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1212\/01.wnl.0000186800.18456.72","volume":"65","author":"J.E. Pina-Garza","year":"2005","unstructured":"Pina-Garza JE, Espinoza R, Nordli D, et al.: Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology 2005, 65:1370\u20131375.","journal-title":"Neurology"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.yebeh.2006.04.021","volume":"9","author":"R.C. Sachdeo","year":"2006","unstructured":"Sachdeo RC, Gates JR, Bazil CW, et al.: Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Epilepsy Behav 2006, 9:457\u2013463.","journal-title":"Epilepsy Behav"},{"key":"12_CR7","doi-asserted-by":"crossref","unstructured":"Posner EB, Mohamed K, Marson AG: Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2005, 19:CD003032.","DOI":"10.1002\/14651858.CD003032.pub2"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","volume":"52","author":"R.C. Sachdeo","year":"2000","unstructured":"Sachdeo RC, Glauser TA, Ritter F, et al.: A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 2000, 52:1882\u20131887.","journal-title":"Neurology"},{"issue":"Suppl5","key":"12_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.0013-9580.2004.05004.x","volume":"45","author":"J.A. Conry","year":"2004","unstructured":"Conry JA: Pharmacologic treatment of the catastrophic epilepsies. Epilepsia 2004, 45(Suppl 5):12\u201316.","journal-title":"Epilepsia"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","volume":"62","author":"M.T. Mackay","year":"2004","unstructured":"Mackay MT, Weiss SK, Adams-Webber T, et al.: Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004, 62:1668\u20131681.","journal-title":"Neurology"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","volume":"57","author":"R.D. Elterman","year":"2001","unstructured":"Elterman RD, Shields WD, Mansfield KA, et al.: Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001, 57:1416\u20131421.","journal-title":"Neurology"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/01.WNL.0000103284.73495.35","volume":"62","author":"T.E. Lotze","year":"2004","unstructured":"Lotze TE, Wilfong AA: Zonisamide treatment for symptomatic infantile spasms. Neurology 2004, 62:296\u2013298.","journal-title":"Neurology"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/awh726","volume":"129","author":"M. Sillanpaa","year":"2006","unstructured":"Sillanpaa M, Schmidt D: Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006, 129:617\u2013624.","journal-title":"Brain"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.20852","volume":"60","author":"A.T. Berg","year":"2006","unstructured":"Berg AT, Vickrey BG, Testa FM, et al.: How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol 2006, 60:73\u201379.","journal-title":"Ann Neurol"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1212\/01.wnl.0000197788.38783.09","volume":"66","author":"M. Sabaz","year":"2006","unstructured":"Sabaz M, Lawson JA, Cairns DR, et al.: The impact of epilepsy surgery on quality of life in children. Neurology 2006, 66:557\u2013561.","journal-title":"Neurology"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.braindev.2006.06.009","volume":"29","author":"S. Liu","year":"2007","unstructured":"Liu S, An N, Yang H, et al.: Pediatric intractable epilepsy syndromes: reason for early surgical intervention. Brain Dev 2007, 29:69\u201378.","journal-title":"Brain Dev"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2007.00914.x","volume":"48","author":"A.L. Hartman","year":"2007","unstructured":"Hartman AL, Vining E: Clinical aspects of the ketogenic diet. Epilepsia 2007, 48:31\u201342.","journal-title":"Epilepsia"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1528-1157.2002.11302.x","volume":"43","author":"E.H. Kossoff","year":"2002","unstructured":"Kossoff EH, Pyzik PL, Furth SL, et al.: Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet. Epilepsia 2002, 43:1168\u20131171.","journal-title":"Epilepsia"},{"key":"12_CR19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1528-1167.2006.00438.x","volume":"47","author":"E.H. Kossoff","year":"2006","unstructured":"Kossoff EH, McGrogan JR, Bluml RM, et al.: A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 2006, 47:421\u2013424.","journal-title":"Epilepsia"},{"key":"12_CR20","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1212\/01.wnl.0000187071.24292.9e","volume":"65","author":"H.H. Pfeifer","year":"2005","unstructured":"Pfeifer HH, Thiele EA: Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology 2005, 65:1810\u20131812.","journal-title":"Neurology"},{"key":"12_CR21","unstructured":"Physicians\u2019 Desk Reference, edn 61. Montvale, NJ: Thompson Healthcare; 2007."},{"key":"12_CR22","unstructured":"Drug Topics Red Book. Montvale, NJ: Thompson Healthcare; 2007."},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/brain\/awl047","volume":"129","author":"P. Thomas","year":"2006","unstructured":"Thomas P, Valton L, Genton P: Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006, 129:1281\u20131292.","journal-title":"Brain"},{"key":"12_CR24","unstructured":"Canada Pharmacy. http:\/\/www.canadapharmacy.com . Accessed February 13, 2007."},{"key":"12_CR25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/01.WNL.0000138499.87068.C0","volume":"63","author":"B.M. Uthman","year":"2004","unstructured":"Uthman BM, Reichl AM, Dean JC, et al.: Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation. Neurology 2004, 63:1124\u20131126.","journal-title":"Neurology"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.0013-9580.2004.21903.x","volume":"45","author":"M.L. Smith","year":"2004","unstructured":"Smith ML, Elliott IM, Lach L: Cognitive, psychosocial, and family function one year after pediatric epilepsy surgery. Epilepsia 2004, 45:650\u2013660.","journal-title":"Epilepsia"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0733-8619(05)70028-1","volume":"19","author":"N. Foldvary","year":"2001","unstructured":"Foldvary N, Bingaman WE, Wyllie E: Surgical treatment of epilepsy. Neurol Clin 2001, 19:491\u2013515.","journal-title":"Neurol Clin"},{"key":"12_CR28","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1542\/peds.2005-1206","volume":"117","author":"H.L. Weiner","year":"2006","unstructured":"Weiner HL, Carlson C, Ridgway EB, et al.: Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach. Pediatrics 2006, 117:1494\u20131502.","journal-title":"Pediatrics"},{"key":"12_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1528-1167.2006.00377.x","volume":"47","author":"M. Nei","year":"2006","unstructured":"Nei M, O\u2019Connor M, Liporace J, et al.: Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation. Epilepsia 2006, 47:115\u2013122.","journal-title":"Epilepsia"},{"key":"12_CR30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S105913110200225X","volume":"12","author":"D.J. Dalziel","year":"2003","unstructured":"Dalziel DJ, Uthman BM, Mcgorray SP, et al.: Seizurealert dogs: a review and preliminary study. Seizure 2003, 12:115\u2013120.","journal-title":"Seizure"},{"key":"12_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1528-1157.2002.26001.x","volume":"43","author":"M. Hodaie","year":"2002","unstructured":"Hodaie M, Wennberg RA, Dostrovsky JO, et al.: Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 2002, 43:603\u2013608.","journal-title":"Epilepsia"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.wco.0000218233.60217.84","volume":"19","author":"M. Morrell","year":"2006","unstructured":"Morrell M: Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? Curr Opin Neurol 2006, 19:164\u2013168.","journal-title":"Curr Opin Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-007-0012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-007-0012-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-007-0012-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:51Z","timestamp":1559422611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-007-0012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11940-007-0012-7","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}